Alpha Teknova Inc（TKNO）股票分析TKNOAlpha Teknova Inc

Alpha Teknova, Inc. is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. The Company offers three primary product types: pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. It offers a range of standard and specialty pre-poured media plates for a variety of applications including bacteria, fungi, and nematode growth. Its two primary product categories include Lab Essentials and Clinical Solutions. Its core Lab Essentials products consist of commonly used catalog solutions and customer-specified formulations. Its Clinical Solutions products are custom products used in the development and production of protein therapies, gene therapies, mRNA vaccines, and diagnostic kits. It operates in the Healthcare sector (IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES industry).

Alpha Teknova Inc (TKNO) appears to be a good buy right now. The current price is $6.42, and analysts have set a price target of $9, indicating a potential upside of approximately 40%. The company reported a significant revenue growth of 18% in Q2 2026, reaching over $12 million, which is the highest quarterly revenue in its history. However, there is a risk with the forward P/E ratio being 0, indicating uncertainty in future earnings expectations.